Smartwatches have been gradually becoming a crucial part of our day-to-day lives. Wear OS-powered watches, including the likes from Samsung Galaxy watches or any other OS, significantly pack a collection of health-centred features like SpO2 monitoring and more; however, the measurement is not accurate, and thus, Masimo is dedicatedly bringing a new technology to Wear OS-based smartwatches for more accurate blood oxygen level tracking.
Masimo, a big name, has recently made its intentions very clear that it’s working on a new biosensing technology, which will be equipped within the Wear OS-based smartwatches in order to track the blood oxygen level (SpO2) more precisely.
The company main aim is to offer a more accurate measurement of the blood oxygen level, alongside other health tracking features, including sleep apnoea and sleep analysis. Also, the company emphasised introducing such wearables incorporating several health-based features, such as a SpO2 tracker.
Also, Masimo has even reached Google with the agreement that it’s going to bring a new technology for tracking SpO2 level to Wear OS watches, while it further forced Apple to pause the selling of the Watch 9 and Watch Ultra 2 in the US amidst breaking certain patents for technology.
Meanwhile, Masimo has also gained approval from the US FDA (Food and Drug Administration), which significantly suggests that the Wear OS-powered smartwatches will soon be able to take advantage of this newest technology, which will aim to offer a more precise blood oxygen level monitoring while also tracking the overall health and wellness of the users remotely that are suffering from certain chronic diseases.
Lastly, the new biosensing technology will be incorporated in the Wear OS-based smartwatches, suggesting that Galaxy watch owners will soon be able to monitor their blood oxygen level (SpO2) more accurately in order to keep their health in check and to prevent some chronic disease.
Via – The Verge
